Published in TB and Outbreaks Week, December 1st, 2009
"The compounds 2 and 3 showed strong anti-mycobacterial activity against Mycobacterium smegmatis and M. bovis Bacille de Calmette et Guerin (BCG) under both aerobic condition and hypoxic condition inducing dormant state...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week